Food Companies Face Challenges as GLP-1 Weight Loss Drugs Change Consumer Habits

This report highlights how the adoption of GLP-1 medications for weight loss is impacting consumer behavior, with people buying less food, reducing portion sizes, and purchasing smaller clothing. Food companies are struggling to adapt to these shifts in demand and consumption patterns.

Originally published by nyt